Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that ...
Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, MBBS, PhD, MBA. The dual glucose-dependent insulinotropic polypeptide (GIP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results